DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Vermehren J, Dietz J, Peiffer KH. , et al.
Resistance analysis in direct-acting antiviral-experienced patients with chronic hepatitis C virus infection treated with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX). Results from the Frankfurt Resistance Database.
Hepatology 2018;
68 (Suppl.): 397A
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.